Benno Rattel

A novel BCMA/CD3 bispecific T-cell engager for the treatment of multiple myeloma induces selective lysis in vitro and in vivo

Susanne Hipp, YT Tai, Diann Blanset et al. · Leukemia · 2016 · 228 citations · Full text

Hematological Malignancy, Cancer Immunosurveillance, Malignant Blood Disorder +11

T cell-engaging BiTE antibodies specific for EGFR potently eliminate KRAS- and BRAF-mutated colorectal cancer cells

Ralf Lutterbuese, Tobias Raum, Roman Kischel et al. · Proceedings of the National Academy of Sciences · 2010 · 160 citations · Full text

Braf-mutated Crc Lines, Cancer Immunosurveillance, Low Doses Growth +11

Fully human, HLA-DR-specific monoclonal antibodies efficiently induce programmed death of malignant lymphoid cells

Zoltan A. Nagy, Bernd Hubner, Corinna Löhning et al. · Nature Medicine · 2002 · 142 citations

Lymphoid Neoplasia, Hla-dr-specific Monoclonal Antibodies, Programmed Death +10

Regression of Human Prostate Cancer Xenografts in Mice by AMG 212/BAY2010112, a Novel PSMA/CD3-Bispecific BiTE Antibody Cross-Reactive with Non-Human Primate Antigens

Matthias Friedrich, Tobias Raum, Ralf Lutterbuese et al. · Molecular Cancer Therapeutics · 2012 · 142 citations

Preclinical Characterization of AMG 330, a CD3/CD33-Bispecific T-Cell–Engaging Antibody with Potential for Treatment of Acute Myelogenous Leukemia

Matthias Friedrich, Anja Henn, Tobias Raum et al. · Molecular Cancer Therapeutics · 2014 · 134 citations · Full text

Hematological Malignancy, Cell Therapy, Immunology +14